Because of the adoption of immune checkpoint inhibitor and targeted therapies since 2011, the therapeutic landscape of melanoma has changed dramatically.
Publications
Biomarker May Predict Treatment Outcome in Advanced Melanoma
Among patients receiving targeted therapy for advanced melanoma, BRAF V600-mutant cell-free circulating tumor DNA (ctDNA) measurements potentially could predict clinical outcome, according to a study published online Feb
Structured Surveillance Program May Provide Earlier Detection of Melanoma
A study evaluated the feasibility and success of a structured surveillance program at skin clinics to help achieve earlier detection of melanoma.
Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy.